OLANIB (Olaparib):A High-Quality Generic Alternative to LYNPARZA® Olaparib in Advanced Ovarian Cancer with Past Achievements and Future Horizons Olaparib in Germline BRCA Mutated Metastatic Breast Cancer Based on Evidence from the OlympiAD Trial Olaparib in Patients With Pancreatic Cancer and BRCA1 or BRCA2 Mutations Based on Findings From the TAPUR Study Olaparib in Metastatic Castration-Resistant Prostate Cancer from the PROfound Study
Olaparib in Patients With Pancreatic Cancer and BRCA1 or BRCA2 Mutations Based on Findings From the TAPUR Study